• 제목/요약/키워드: Neonatal hypotonia

검색결과 21건 처리시간 0.025초

경련을 동반한 신생아 부신백질이영양증 (Neonatal Adrenoleukodystrophy Presenting with Neonatal Seizure)

  • 신영림;유한욱
    • 대한유전성대사질환학회지
    • /
    • 제2권1호
    • /
    • pp.15-19
    • /
    • 2002
  • Disorders resulting from defects in peroxisomal biogenesis include Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. The three diseases are now considered as a continuum of clinical features. Neonatal adrenoleukodystrophy is intermediate between Zellweger syndrome and infantile Refsum disease in severity, and is characterized by profound hypotonia, intractable seizures and premature death. We report a cases of neonatal adrenoleukodystrophy presenting with neonatal seizure and hypotonia. At the age of 43 months, she had clinical evidence of adrenal insufficiency with skin hyperpigmentation and electrolyte imbalance. She was diagnosed having neonatal adrenoleukodystrophy based on abnormally high levels of plasma very long-chain fatty acids, pipecolic acid and phytanic acid.

  • PDF

A novel association between cerebral sinovenous thrombosis and nonketotic hyperglycinemia in a neonate

  • Yurttutan, Sadik;Oncel, Mehmet Yekta;Yurttutan, Nursel;Degirmencioglu, Halil;Uras, Nurdan;Dilmen, Ugur
    • Clinical and Experimental Pediatrics
    • /
    • 제58권6호
    • /
    • pp.230-233
    • /
    • 2015
  • Lethargy in newborns usually indicates central nervous system dysfunction, and many conditions such as cerebrovascular events, infections, and metabolic diseases should be considered in the differential diagnosis. Nonketotic hyperglycinemia is an autosomal recessive error of glycine metabolism, characterized by myoclonic jerks, hypotonia, hiccups, apnea, and progressive lethargy that may progress to encephalopathy or even death. Cerebral sinovenous thrombosis is a rare condition with various clinical presentations such as seizures, cerebral edema, lethargy, and encephalopathy. Here, we report the case of a newborn infant who presented with progressive lethargy. An initial diagnosis of cerebral venous sinus thrombosis was followed by confirmation of the presence of nonketotic hyperglycinemia.

X-linked recessive myotubular myopathy with MTM1 mutations

  • Han, Young-Mi;Kwon, Kyoung-Ah;Lee, Yun-Jin;Nam, Sang-Ook;Park, Kyung-Hee;Byun, Shin-Yun;Kim, Gu-Hwan;Yoo, Han-Wook
    • Clinical and Experimental Pediatrics
    • /
    • 제56권3호
    • /
    • pp.139-142
    • /
    • 2013
  • X-linked recessive myotubular myopathy (XLMTM) is a severe congenital muscle disorder caused by mutations in the MTM1 gene and characterized by severe hypotonia and generalized muscle weakness in affected males. It is generally a fatal disorder during the neonatal period and early infancy. The diagnosis is based on typical histopathological findings on muscle biopsy, combined with suggestive clinical features. We experienced a case of a newborn who required intubation and ventilator care because of profound hypotonia and respiratory difficulty. The preliminary diagnosis at the time of request for retrieval was hypoxic ischemic encephalopathy, but the infant was clinically reevaluated for generalized weakness and muscle atrophy. Muscle biopsies showed variability in fiber size and centrally located nuclei in nearly all the fibers. We detected an MTM1 gene mutation of c.1261-1C>A in the intron 10 region, and diagnosed the neonate with myotubular myopathy. The same mutation was detected in his mother.

신생아기의 유전성대사이상질환의 체계적 접근방법 (Systematic Approach for the Diagnosis of IEM in the Neonatal Period)

  • 이홍진
    • 대한유전성대사질환학회지
    • /
    • 제14권1호
    • /
    • pp.10-18
    • /
    • 2014
  • Recent advances in the diagnosis and treatment of inborn errors of metabolism have improved substantially the prognosis of many of these diseases, if diagnosed early enough before irreversible damage occurs. This makes it essential that the practicing pediatrician, especially neonatologists be familliar with the clinical presentations and systematic approaches of these disorders. Characteristic clinical presentations, methods of systematic approach and typing of various disorders is discussed in this review. The signs of neurological dysfunctions of many IEMs manifesting in the neonatal period is very nonspecific, such as poor feeding, poor sucking, apnea or tachypnea, vomiting, hypertonia, hypotonia, seizure, letharginess, consciousness change and coma. Many other non-metabolic severe disorders of neonatal period such as neonatal sepsis and intracerebral hemorrhage share these nonspecific symptoms. Hyperammonemia, metabolic acidosis, ketosis and hyperlatic acidemia are observed in many of these conditions but there are exceptions in which conditions all basal laboratory tests are normal, such as NKH, sulfite oxidase deficiency and peroxisomal disorders. According to the results of basal laboratory tests, IEMs in the neonatal period can be categorized in to 6 types. Grouping of IEMs into 6 types will make confirmatory tests and early emergency treatment more efficient.

A Korean Case of Neonatal Nemaline Myopathy Carrying KLHL40 Mutations Diagnosed Using Next Generation Sequencing

  • Suh, Yoong-a;Sohn, Young Bae;Park, Moon Sung;Lee, Jang Hoon
    • Neonatal Medicine
    • /
    • 제28권2호
    • /
    • pp.89-93
    • /
    • 2021
  • Nemaline myopathy is a genetically heterogeneous neuromuscular disorder and one of the most common congenital myopathies. The clinical manifestations usually vary depending on the age of onset. Neonatal nemaline myopathy has the worst prognosis, primarily due to respiratory failure. Several genes associated with nemaline myopathy have been identified, including NEB, ACTA1, TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, LMOD3, and KBTBD13. Here, we report a neonatal Korean female patient with nemaline myopathy carrying compound heterozygous mutations in the gene KLHL40 as revealed using next generation sequencing (NGS). The patient presented with postnatal cyanosis, respiratory failure, dysphagia, and hypotonia just after birth. To identify the genetic cause underlying the neonatal myopathy, NGS-based gene panel sequencing was performed. Compound heterozygous pathogenic variants were detected in KLHL40: c.[1405G>T];[1582G>A] (p. [Gly469cys];[Glu528Lys]). NGS allows quick and accurate diagnosis at a lower cost compared to traditional serial single gene sequencing, which is greatly advantageous in genetically heterogeneous disorders such as myopathies. Rapid diagnosis will facilitate efficient and timely genetic counseling, prediction of disease prognosis, and establishment of treatments.

미숙아에서의 6p23 Deletion Syndrome 1례 (6p23 Deletion Syndrome : Report of a Case in a Preterm Baby)

  • 이현수
    • Clinical and Experimental Pediatrics
    • /
    • 제46권1호
    • /
    • pp.83-85
    • /
    • 2003
  • 저자는 재태연령 30주, 출생체중 1,100 g의 미숙아에서 출생시 양안의 무안구증, 극심한 처짐, 양안 격리증, 낮은 코, 짧은 목, 저이개, 소악증, 양측성 뇌수종, 양손의 simian line이 관찰되었기에 시행한 임파구 배양 검사상 46, XX, del(6)(p23)의 소견을 보여 이탈점이 6p23으로 판명된 terminal deletion 6p23, 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

경한 임상 경과를 보인 신생아 시기의 프로피온산혈증 1례 (A Case of Neonatal Onset Propionic Acidemia with Mild Clinical Presentations)

  • 김경란;김진섭;허림;박형두;조성윤;진동규
    • 대한유전성대사질환학회지
    • /
    • 제16권1호
    • /
    • pp.47-51
    • /
    • 2016
  • 프로피온산혈증은 상염색체 열성유전에 의해 발생하는 질환으로, 혈중에 암모니아, 독성 물질 등이 축적되어 경한 증상에서부터 사망에까지 이르는 질환이다. 유병률은 50,000-100,000명당 1명이다. PCCA 또는 PCCB 유전자의 돌연변이로 발생하며, 이것을 규명하는 것이 가장 확실한 진단 방법이다. 두 유형에 따른 임상경과 차이는 뚜렷하게 밝혀져 있지 않다. 발병 시기에 따라 신생아기형과 후기형으로 나눌 수 있다. 증상 발현의 원인은 이화작용을 강화시키는 감염, 스트레스, 변비, 단백질의 과도한 섭취 등이며, 운동실조, 이상행동, 식욕부진, 주기적 구토, 성장장애, 신경발달이상 등의 광범위한 임상 경과를 보인다. 정확한 진단과 조속한 초기 치료가 환자의 생존율 및 신경 발달 장애 여부에 중요한 요소이다. 본 증례는 고암모니아혈증 및 대사산증이 심하지 않았으나 조기에 대사성 질환을 염두에 두고 PCCA와 PCCB 유전자의 돌연변이를 분석하여 프로피온산혈증을 진단하고 적극적인 금식 및 수액 치료와 진단을 통해 신체 발달 및 운동 및 치명적인 신경학적 장애 없이 성장한 고무적인 사례로 이를 보고하는 바이다.

  • PDF

신석회화와 소뇌 충부의 무형성을 동반한 Joubert 증후군 1례 (A Case of Joubert Syndrome Associated with Nephrocalcinosis and Agenesis of Cerebellar Vermis)

  • 김지희;신혜경;홍영숙;이주원;김순겸;유기환
    • Childhood Kidney Diseases
    • /
    • 제6권2호
    • /
    • pp.266-271
    • /
    • 2002
  • Joubert 증후군은 소뇌 충부 무형성을 특징으로 하며 근 긴장 저하, 불규칙적인 호흡, 발달 지연, 안진, 망막 이형성, 낭종성 신질환, 간 섬유증, 다지증 등이 동반되는 증후군이다. 이 질환에서는 소뇌 충부의 병변과 신장의 병변이 무작위적으로 함께 나타나기도 하는데, 저자들은 소뇌 충부 무형성, 근 긴장저하, 안진, 무호흡 등이 있어 Joubert 증후군으로 진단받은 환아가 신장 수질 석회화 병변과 만성 신부전으로 진행한 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

  • PDF

신생아기에 진단된 미토콘드리아 질환 3례 (Three Cases of Mitochondrial Disorders in the Neonatal Period)

  • 김윤희;이영목;남궁란;김정은;이순민;박국인;김세훈;이진성
    • Neonatal Medicine
    • /
    • 제17권2호
    • /
    • pp.254-261
    • /
    • 2010
  • 신생아에서의 미토콘드리아 질환은 임상 증상이 다양하고 비특이적이라 진단이 어렵고, 치명적으로 생존율이 낮기 때문에 이에 대한 연구는 미비하다. 본 연구에서는 신생아기에 미토콘드리아 질환 소견으로 치료한 3례를 보고하였다. 증례 1은 갑작스럽게 발생한 강직성 경련, 의식 소실 및 심한 대사성 산증과다기관 기능 부전으로 미토콘드리아 병증이 의심되었다. 혈장내 젖산/피루브산염 비가 55.6, 아미노산 검사에서는 알라닌 2,237 nmol/ml로 증가되었다. 증례 2에서는 급성 부신기능부전과 급성 신부전으로 복막 투석을 하였으나 대사성 산증이 지속되었다. 혈장 내 젖산/피루브산염 비가 23.9였고, 근 조직을 이용한 효소 분석에서 1번 복합체의 호흡 사슬 결함이 진단되었다. 증례 3은 출생 후 2개월간 반복되는 대사성 산증과 기면, 수유 곤란 소견을 보였다. 혈장 내 젖산/피루브산염 비가 19.4로 정상 범위의 경계에 있었으나 뇌척수액 검사상 젖산/피루브산염 비가 57로 현저하게 증가된 소견을 보였고, 뇌 자기 공명 분광경 검사에서 lactate peak 소견을 보였다. 근 조직을 이용한 효소 분석에서 2번 복합체의 호흡 사슬 결함이 진단되었다. 세증례 모두에서 미토콘드리아 질환 소견으로 비타민, 조효소 Q10 및 L-카르니틴을 투여하였다.

Systematic review of the clinical and genetic aspects of Prader-Willi syndrome

  • Jin, Dong-Kyu
    • Clinical and Experimental Pediatrics
    • /
    • 제54권2호
    • /
    • pp.55-63
    • /
    • 2011
  • Prader-Willi syndrome (PWS) is a complex multisystem genetic disorder that is caused by the lack of expression of paternally inherited imprinted genes on chromosome 15q11-q13. This syndrome has a characteristic phenotype including severe neonatal hypotonia, early-onset hyperphagia, development of morbid obesity, short stature, hypogonadism, learning disabilities, behavioral problems, and psychiatric problems. PWS is an example of a genetic condition caused by genomic imprinting. It can occur via 3 main mechanisms that lead to the absence of expression of paternally inherited genes in the 15q11.2-q13 region: paternal microdeletion, maternal uniparental disomy, and an imprinting defect. Over 99% of PWS cases can be diagnosed using DNA methylation analysis. Early diagnosis of PWS is important for effective long-term management. Growth hormone (GH) treatment improves the growth, physical phenotype, and body composition of patients with PWS. In recent years, GH treatment in infants has been shown to have beneficial effects on the growth and neurological development of patients diagnosed during infancy. There is a clear need for an integrated multidisciplinary approach to facilitate early diagnosis and optimize management to improve quality of life, prevent complications, and prolong life expectancy in patients with PWS.